NCT05897099

Comprehensive HIV and Harm Prevention Via Telehealth

Comprehensive HIV and Harm Prevention Via Telehealth: CHARIOT, a Randomized Controlled Trial

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 350 (estimated)
• Sponsor: University of Miami · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to test 2 different ways to offer medications to prevent human immunodeficiency virus (HIV), cure hepatitis C virus (HCV) (if applicable) and treat substance use disorder (if desired) in people who inject drugs.

Conditions

• HIV Infections

Interventions

Type	Name	Description
BEHAVIORAL	Comprehensive Tele-harm Reduction	Comprehensive Tele-Harm Reduction is on-demand services including low-barrier access to PrEP, medications for substance use disorder and hepatitis C treatment. It includes mobile phlebotomy, peer harm reduction counseling, medication management, telehealth mental health/substance use disorder services-- all delivered via an syringe services program.
BEHAVIORAL	Off-site Linkage to HIV Prevention	The community engagement team is comprised of peers and social workers and provides the wraparound support needed.The team will assist participants in scheduling appointments at community health clinics. The community engagement team provides active clinic referral- that is, a member of the team will accompany patients to the first clinic visit.

Timeline

• Start date: 2024-10-07
• Primary completion: 2028-03-31
• Completion: 2028-05-31
• First posted: 2023-06-09
• Last updated: 2026-02-17

Locations

2 sites across 1 country: United States